Minimizing the risks of anticoagulants and platelet inhibitors.
Alexander
Karen P
KP
Department of Medicine, Duke University Medical Center, Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA.
Peterson
Eric D
ED
D054058:Acute Coronary Syndrome / Q000188:drug therapy* / Q000453:epidemiology; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D003324:Coronary Artery Disease / Q000188:drug therapy* / Q000453:epidemiology; D003328:Coronary Thrombosis / Q000453:epidemiology / Q000517:prevention & control*; D006470:Hemorrhage / Q000139:chemically induced* / Q000453:epidemiology; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D012307:Risk Factors
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors